A research team led by the Duke-NUS Graduate Medical School in Singapore has identified ways to inhibit the function of a key protein linked to stem cell-like behavior in terminal-stage chronic myeloid leukemia , making it possible to develop drugs that may extend the survival of these patients.
http://www.medilexicon.com/medicalnews.php?newsid=261425
http://www.medilexicon.com/medicalnews.php?newsid=261425
No comments:
Post a Comment